Ask Warren

Samil Pharmaceutical

000520 · KOSPI · ₩000520 · 삼일제약

₩7,650▼ ₩40 (0.52%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩51B₩53B₩53B₩51B₩54B₩52B₩58B₩53B
Cost of sales₩32B₩35B₩34B₩33B₩33B₩34B₩37B₩34B
Gross profit₩19B₩17B₩19B₩18B₩21B₩18B₩21B₩19B
Operating income−₩6.3B−₩8.4B−₩8.6B−₩5.2B−₩3.1B−₩5.4B−₩2.9B−₩240M
Net income₩3.1B−₩11B−₩27B−₩1.4B₩2.6B−₩9.1B−₩5B−₩1B
Net income to shareholders−₩7.7B−₩11B−₩11B−₩7.9B−₩6.5B−₩9.1B−₩3.6B−₩676M

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩375B₩372B₩372B₩377B₩376B₩396B₩395B₩384B
Current assets₩76B₩75B₩82B₩89B₩88B₩96B₩91B₩87B
Cash and equivalents₩6.1B₩1.2B₩6.4B₩6.5B₩2.7B₩1.1B₩5.1B₩4B
Total liabilities₩249B₩244B₩238B₩234B₩226B₩230B₩219B₩210B
Current liabilities₩160B₩164B₩185B₩147B₩139B₩141B₩107B₩116B
Borrowings₩174B₩164B₩162B₩162B₩157B₩156B₩148B₩144B
Total equity₩126B₩129B₩133B₩143B₩149B₩166B₩176B₩175B
Shareholders' equity₩126B₩129B₩133B₩143B₩149B₩166B₩176B₩175B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩3.5B₩487M₩5.3B₩2.8B₩2.4B−₩10B₩2.4B₩627M
Capital spending₩461M₩3.3B₩2.6B₩1B₩3.3B₩613M₩2B₩1.8B
Free cash flow−₩3.9B−₩2.8B₩2.7B₩1.8B−₩811M−₩11B₩437M−₩1.2B
Dividends paid——₩0₩0₩0₩0₩0₩0

Consolidated where available. Amounts in won.

Also known as: Samil Pharmaceutical / 삼일제약 / 000520 / KRX:000520

Source: KRX statistical information